Can-Fite BioPharma Ltd. (CANF)
1.90
-0.10
(-5.00%)
USD |
NYAM |
Oct 09, 16:00
1.91
+0.01
(+0.53%)
After-Hours: 20:00
Can-Fite BioPharma EPS Diluted (Quarterly)
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.363 |
| September 30, 2023 | -0.438 |
| June 30, 2023 | -0.408 |
| March 31, 2023 | -0.648 |
| December 31, 2022 | -1.11 |
| September 30, 2022 | -0.93 |
| June 30, 2022 | -0.807 |
| March 31, 2022 | -0.894 |
| December 31, 2021 | -3.306 |
| September 30, 2021 | -1.695 |
| June 30, 2021 | -1.872 |
| March 31, 2021 | -1.164 |
| December 31, 2020 | -2.349 |
| September 30, 2020 | -1.671 |
| June 30, 2020 | -3.00 |
| March 31, 2020 | -7.533 |
| December 31, 2019 | -4.341 |
| September 30, 2019 | -8.868 |
| June 30, 2019 | -11.75 |
| March 31, 2019 | -12.25 |
| December 31, 2018 | -25.46 |
| September 30, 2018 | -1.344 |
| June 30, 2018 | -9.444 |
| March 31, 2018 | -15.00 |
| December 31, 2017 | -307.86 |
| Date | Value |
|---|---|
| September 30, 2017 | -215.84 |
| June 30, 2017 | -323.50 |
| March 31, 2017 | -319.38 |
| December 31, 2016 | -20.36 |
| September 30, 2016 | -22.87 |
| June 30, 2016 | -14.94 |
| March 31, 2016 | -16.13 |
| December 31, 2015 | 3.095 |
| September 30, 2015 | -43.66 |
| June 30, 2015 | -24.03 |
| March 31, 2015 | -4.560 |
| December 31, 2014 | -31.34 |
| September 30, 2014 | -21.32 |
| June 30, 2014 | -29.45 |
| March 31, 2014 | -31.75 |
| December 31, 2013 | -73.20 |
| September 30, 2013 | -28.46 |
| June 30, 2013 | -33.07 |
| March 31, 2013 | -40.48 |
| December 31, 2012 | -39.01 |
| September 30, 2012 | -37.65 |
| June 30, 2012 | -39.21 |
| March 31, 2012 | -19.89 |
| December 31, 2011 | -99.71 |
| September 30, 2011 | -21.10 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioLineRx Ltd. | -0.6957 |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 0.1605 |
| Eocene Ltd. | -2.860 |
| Revium Recovery, Inc. | -0.0096 |
EPS Diluted (Quarterly) Related Metrics
| Enterprise Value | -4.811M |
| Earnings Yield | -331.5% |
| Normalized Earnings Yield | -331.45 |